重组人F7, Coagulation factor VII蛋
白 | Recombinant Human F7/Coagulation factor VII Protein, 213-466aa, His-tag- 询价
- Nebulabio
- 中国
- NBL-296744
- 2026年01月16日
企业认证
相关产品推荐更多 >
![杆菌肽, HSA [抗原]](https://img1.dxycdn.com/p/s14/2025/0919/675/8657573427686398691.jpg!wh200)
![Digitoxin, KLH [Antigen]](https://img1.dxycdn.com/p/s14/2025/0919/905/8275649941890498691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human F7/Coagulation factor VII Protein, 213-466aa, His-tag
中文名称：重组人F7, Coagulation factor VII蛋白
别名：F7, Proconvertin, SPCA, Serum prothrombin conversion accelerator, Coagulation factor VII, Eptacog alfa
货号：NBL-296744
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Human F7/Coagulation factor VII Protein, His-tag (Cat# NBL-296744) is E. coli with His Tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Human
Expression System:E. coli
Molecular Weight:30 kDa
Target Name:F7, Coagulation factor VII
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Identification of Mutations in the Human Factor VII Gene
It has been recognized from the early 1800s that activation of coagulation can be initiated by the exposure of subendothelial layers (tissue factor), but it was the 1940s before factor VII (FVII) was included in this event
Use of Human Hepatocytes to Investigate Blood Coagulation Factor
is to describe experimental procedures allowing to measure the secretion by primary human hepatocytes and functional activity (including production of fibrillar material from extracellular medium) of haemostasis proteins including factors II, V, VII, VIII, PIVKA-II (protein
Studies on Coagulation Incompatibilities for Xenotransplantation
) circulating PC in the presence of thrombin. Tissue factor pathway inhibitor (TFPI), is the primary inhibitor of tissue factor (TF)-induced coagulation. TFPI directly inhibits the activated factor X (FXa) and blocks the procoagulant activity of the TF/factor
技术资料暂无技术资料 索取技术资料
